An interventional study of single leg exercise intervantion in COPD in Exercise, sponsored by Hacettepe University. Recruiting at 1 site in Turkey. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2024-06-24.
Sponsored by Hacettepe University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 18 studies in Pulmonary Disease, Chronic Obstructive by Hacettepe University — 10 open to participants now, 12 under way, none of them phase 3. Pulmonary Disease, Chronic Obstructive · Hacettepe University.
Among the 18 studies in Pulmonary Disease, Chronic Obstructive by Hacettepe University, this one is one of 2 that started in 2023, is one of 6 with no phase, reaches primary completion later than 2 of the 11 other live ones, and was the 8th registered.
5,529 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 858 are open to participants now.
Browse Pulmonary Disease, Chronic Obstructive studies →10 of the 18 studies in Pulmonary Disease, Chronic Obstructive by Hacettepe University are open now, in 1 country. Recruiting first, the newest first:
Hacettepe University · Sites in Turkey
Ages 40+ · Healthy volunteers
Hacettepe University · Sites in Turkey
Ages 40+ · Healthy volunteers
Hacettepe University · Sites in Turkey
Ages 40–65 · Healthy volunteers
Hacettepe University · Sites in Turkey
Ages 40+
Hacettepe University · Sites in Turkey
Ages 40+
By country, each count listing its studies:
Of the 560 Pulmonary Disease, Chronic Obstructive studies recruiting now, 307 (55%) set no upper age limit and 82 (15%) stop at 75 or younger; 30 take children under 18; 88 take healthy volunteers.
This study: 40 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
18 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 2 started in 2023.
This study's planned enrollment of 66 is close to the median of 62 across 3,847 interventional studies indexed under Pulmonary Disease, Chronic Obstructive.
Median enrollment 42 across the 6 interventional studies, 45 across the 12 observational. Of the 5 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Hacettepe University is the lead sponsor of 1,009 studies on the registry; 214 are open to participants now.
2 of the studies in Pulmonary Disease, Chronic Obstructive by Hacettepe University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06497816Hacettepe UniversityHealth Literacy, Physical and Cognitive Function, Health-related Behaviors, and Quality of Life in COPD | 2027-06-15 |
| NCT07801547Hacettepe UniversityMuscle Oxygenation in Patients With COPD Exacerbation | 2027-10-05 |
Add all 2 to your calendar (.ics) → With an account.
Among the 18 studies in Pulmonary Disease, Chronic Obstructive by Hacettepe University, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
COPD presents not only respiratory symtoms but also vascular or muscle dysfunction. Exercise limitation is observed in COPD. Especially, decreased exercise performance related to vascular and fatique in quadriceps muscle. Exercise training is important for aerobic performance increasing. Generally results show exercise training with both lower limb. Increaed arterial stiffness and fatigue are observed in COPD. One leg exercise training result is not enough to highlight these parameters.
Three types single leg exercise intervantion will be applied. Exercise capacity, muscle strength, lung function, electromyography, lactate and quality of life will be measured.
Three types single leg exercise intervantion will applied to COPD patients that devided three groups. One leg continuous exercise training will be aplied to one group. One leg HIIT exercise training will be aplied to other group. One leg resistance exercise training will be aplied to the last group.
Exercise capacity and muscle strength are assesed. Lung function is measured. Electormyography is recorded. Lactate and quality of life are measured.
5,529 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 858 are open to participants now.
This study's planned enrollment of 66 is close to the median of 62 across 3,847 interventional studies indexed under Pulmonary Disease, Chronic Obstructive.
Browse Pulmonary Disease, Chronic Obstructive studies →Hacettepe University is the lead sponsor of 1,009 studies on the registry; 214 are open to participants now.
Compared within Pulmonary Disease, Chronic Obstructive, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Motor Activity. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
single leg resistance exercise intervantion in COPD will be perfomed at six weeks
Other: single leg exercise intervantion in COPD
single leg continous exercise intervantion in COPD will be perfomed at six weeks
Other: single leg exercise intervantion in COPD
single leg high intensity exercise intervantion in COPD will be perfomed at six weeks
Other: single leg exercise intervantion in COPD
single leg exercise intervantions 1. high intensity interval training 2. continous exercise training 3. resistance exercise training
Also known as: single leg exercise intervantion
six minute walk test
six minute walk test in meter
Time frame: pre-intervention
cardiopulmonary exercise test
VO2 as ml/kg/min will be recorded from incremental cycle cpet test
Time frame: beginning day 2
one leg cardiopulmonary exercise test
VO2 as ml/kg/min will be recorded from incremental cycle cpet test
Time frame: beginning, day 3
quadriceps muscle strength assesing (repeated measeure)
quadriceps muscle 10 repeated max muscle strength will be recorded at kilogram,
Time frame: beginning day 1 and last day
isometrics quadriceps muscle strength assesing
quadriceps muscle isometric muscle strength will be recorded at kilogram
Time frame: beginning day 1 and last day
lung function
FEV1/FVC ratio in %
Time frame: beginning day 1 and last day
quality of life assesing
total score in 0-100 range
Time frame: beginning day 1 and last day
arterial stiffness
total vascular resitance, augmentation index @ 75 and pulse wave velocity wil be determined arterial stiffness
Time frame: beginning day 2 and last day
lactate measurement
lactate in mmol
Time frame: beginning day 2 and last day
electromyography measurement
precentage of maximum volunteer contraction) %MVC values will be presented muscle fatigue (median frequence) and activation will be shown electromyograpy (EMG)
Time frame: beginning day 2 and last day
Started Jun 2023 (actual). Primary completion is estimated for Jan 2025, 18 months after the start.
Of 1,099 non-industry interventional studies with no phase under Pulmonary Disease, Chronic Obstructive, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 18 months is below that.
Counting every sponsor, half of 1,187 studies reached it within 22 months; a quarter within 10 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pulmonary Disease, Chronic Obstructive →